Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: Comparative biodistribution evaluation with 111In-DTPA-Octreotide

Cellular and Molecular Biology

Volumn 56, Issue 2, 2010, Pages 31-36

  Melo, I B ^a   Ueda, L T ^b   Araujo, E B ^b   Muramoto, E ^b   Barboz, M F ^b   Mengatti, J ^b   Buchpiguel, C A ^a   Silva, C P G ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

111In DTPA Oct; 99mTc Hynic Octreotate; 99mTc Hynic Octreotide; Neuroendocrine tumor; Nuclear medicine

Indexed keywords

HYDRAZINONYCOTINIC ACID OCTREOTATE TC 99M; HYDRAZINONYCOTINIC ACID OCTREOTIDE TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADRENAL GLAND; ARTICLE; CONTROLLED STUDY; DENSITY; DRUG DISTRIBUTION; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; LARGE INTESTINE; LIVER; MOUSE; NONHUMAN; PANCREAS; PLASMA CLEARANCE; RADIOCHEMISTRY;

ANIMALS; INTESTINES; KIDNEY; LIGANDS; LIVER; MICE; NEUROENDOCRINE TUMORS; OCTREOTIDE; PENTETIC ACID; PEPTIDES; QUALITY CONTROL; RADIOPHARMACEUTICALS; SOMATOSTATIN; TECHNETIUM; TIME FACTORS; TISSUE DISTRIBUTION;

MUS;

EID: 79959534974     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T891     Document Type: Article

References (20)

1. Breeman W.A.P., Jong M., Kwekkeboom D.J, Valkema R., Bakker W.H., Kooij P.P.M, Visser T.J., Krenning E.P. Somatostatina receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001, 28:1421-1427
2. 111In-Octreotide J Nucl Med 2000, 41:1114-1119
3. Decristoforo C., Mather S.J. Technetium-99m somatostatin analogues: effect of labeling methods and peptide sequence. Eur J Nucl Med 1999, 26:869-876.
4. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours:reasults of 3 years' experience Eur J Nucl Med Mol Imaging 2006, 33:1123-1133
5. Gabriel M., Decristoforo C., Donnemiller E., Ulmer H., Rychlinski C.W., Mather S.J., Moncayo R. An Intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-Octreotide for diagnosis of somatostatin receptor-expressing tumors. J Nucl Med 2003, 44:708-716.
6. 3]-Octreotid e, a somatostatin analog for tumor diagnosis. J Pharm Sci 2004, 93: 2497-2506.
7. 99mTc-EDDA/HYNIC-TOC) J Label Compd Radiopharm 2003, 46:307-318.
8. Kopecky M., Semecky V., Trejtnar F., Laznicek M., Laznickova A., Nachtigal P., Decristoforo C., Mather S.J., Mäcke H.R. Analysis of accumulation os 99mTc-octreotide and 99mTc-EDDA/HYNIC-Try3-octreotide in the rat kidneys. Nuclear and Medicine and Biology 2004, 31: 231-239.
9. Maecke H.R., Behe M. New octreotide derivqtives labeled with technetium-99m. J. Nucl. Med. 1996, 37 (suppl): 29P.
10. 3] octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results. Eur J Nucl Med 2002, 29: 742-753.
11. Signore A., Annovazzi.A, Chianelli M., Corsetti F., Wiele. C.V., Watherhouse R.N., Scopinaro F. Peptide radiopharmaceuticals for siagnosis and terapy Eur. J. Nucl. Méd. 2001, 28:1555-1565.
12. 99mTc. Comision Nacional de Energia Atômica. Centro Atômico Ezeiza. Unidad de Actividad Radioquímica, Radiofármacos.
13. Correia, M. B. L., Magnata, S. S. L. P., Silva, I. M. S., Catanho, M. T. J. A. and Lima, F. F. Biokinetics and dosimetric studies about 99MTC(V)-DMSA distribution. Cell. Mol. Biol., 2010, 56 (2): 1-5.
14. Couto, R. M., De Barboza, M. F., De Souza, A. A., Muramoto, E., Mengatti, J. and De Araújo, E. B. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images. Cell. Mol. Biol., 2010, 56 (2): 6-11.
15. De Araújo, E. B., Pujatti, P. B. and Mengatti, J. Radiolabeling of substance p with lutetium-177 and biodistribution study in rat pancreatic tumor xenografted nude mice. Cell. Mol. Biol., 2010, 56 (2): 12-17.
16. Pujatti, P. B., Santos, J. S., Massicano, A. V. F., Mengatti, J. and De Araújo, E. B. Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in balb-c mice. Cell. Mol. Biol., 2010, 56 (2): 18-24.
17. Yano, V. F. and Lima, F. F. Radiation exposure from diagnostic nuclear medicine in alagoas (Brazil) in 2002-2005. Cell. Mol. Biol., 2010, 56 (2): 25-30.
18. Silva, I C. O. A., Lucena, E. A., Souza, W. O., Dantas, A. L. A. and Dantas, B. M. Estimation of internal exposure to 99mo in nuclear medicine patients. Cell. Mol. Biol., 2010, 56 (2): 37-40.
19. Velasques De Oliveira, S. M., Julião, L. M. Q. C., Sousa, W. O., Mesquita, S. A. and Santos, M. S. Methodology for radionuclides quantification through "in vitro" bioassay. Cell. Mol. Biol., 2010, 56 (2): 31-43.
20. Velasques De Oliveira, S. M., Carlos, M. T., Carneiro, M. P., Da Silva, J. W. E., Kasai, E. P., Oliveira, A. R. N. and Boasquevisque, E. M. Protocol for 18F-FDG quantification in PET-CT whole-body exams. Cell. Mol. Biol., 2010, 56 (2): 44-46.